Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
BioPlus Acquisition Corporation | BIOS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
10.795 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 10.45 - 11.68 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 10.795 | USD |
BioPlus Acquisition Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 147.00M | - | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
BioPlus Acquisition News
Date | Time | Source | News Article |
---|---|---|---|
04/10/2023 | 22:30 | GlobeNewswire Inc. | BioPlus Acquisition Corp. Announces Termination of Business.. |
16/8/2023 | 22:30 | GlobeNewswire Inc. | Heart & Rhythm Institute of Trinity and Avertix Announce.. |
17/7/2023 | 22:00 | GlobeNewswire Inc. | Renown Cardiologist and Professor Ian T. Meredith, MD to.. |
13/6/2023 | 22:30 | GlobeNewswire Inc. | Avertix’s Guardian™ System, First and Only FDA-Approved.. |
03/5/2023 | 22:30 | GlobeNewswire Inc. | Avertix, Maker of First and Only FDA-Approved Implantable.. |
Historical BIOS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 10.45 | 11.68 | 10.45 | 10.56 | 85,323 | 0.345 | 3.30% |
3 Years | 9.81 | 11.68 | 9.78 | 10.32 | 76,752 | 0.985 | 10.04% |
5 Years | 1.63 | 11.68 | 1.56 | 4.05 | 391,791 | 9.17 | 562.27% |